12/17/2025
Developing new cancer drugs can take years of work and major resources. UW Carbone researchers are using artificial intelligence to make those early steps more efficient, and more hopeful.
Drs. Anthony Gitter, Michael Newton and Spencer Ericksen are partnering to create AI tools that help identify promising chemical compounds earlier in the process. Their models combine published research, chemical data and AI technology to suggest which compounds may be worth exploring in the lab.
This work doesnât replace scientists, it supports them. Researchers still review every suggestion, ensuring the science remains sound. But AI can help narrow the field, speed the process and open new paths toward discovery.
đŹ See how Carbone teams are bringing AI into cancer drug development: https://uw.health/48qR2p5